Literature DB >> 10995804

Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.

A B Miller1, T To, C J Baines, C Wall.   

Abstract

BACKGROUND: Screening for breast cancer with mammography in women aged 50 years or more has been shown to reduce mortality from breast cancer. However, the extent to which mammography contributes to the reduction of mortality in women who also undergo physical examination of the breasts is not known. This study was designed to compare breast cancer mortality following annual screening consisting of two-view mammography and physical examination of the breasts with mortality following annual screening by physical examination only. Breast self-examination was taught to all participants.
METHODS: This trial randomly and individually assigned 39 405 women aged 50-59 years, recruited from January 1980 through March 1985, to one of the study arms. The women were followed by record linkage with the Canadian National Cancer Registry and National Mortality Database to December 31, 1993, and by active follow-up of breast cancer patients to June 30, 1996.
RESULTS: Randomization achieved virtually equal distribution of demographic and breast cancer risk variables. At the first annual screen, 21% of the cancers found by mammography alone (in the mammography plus physical examination group) were 20 mm or more in size compared with 46% of those found by physical examination in the mammography plus physical examination group and 56% in the physical examination-only group. The corresponding percentages for screens 2-5 were 10%, 42%, and 50%, respectively. Screening detected 267 invasive breast cancers in the mammography plus physical examination group compared with 148 in the physical examination-only group. By December 31, 1993, 622 invasive and 71 in situ breast carcinomas were ascertained in the mammography plus physical examination group, and 610 and 16 were ascertained in the physical examination-only group. At 13-year follow-up, with 107 and 105 deaths from breast cancer in the respective groups, the cumulative rate ratio was 1.02 (95% confidence interval = 0.78-1.33).
CONCLUSION: In women aged 50-59 years, the addition of annual mammography screening to physical examination has no impact on breast cancer mortality.

Entities:  

Mesh:

Year:  2000        PMID: 10995804     DOI: 10.1093/jnci/92.18.1490

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  67 in total

1.  Detection of breast cancer. Clinical breast examination is not an acceptable alternative to mammography.

Authors:  C J de Wolf
Journal:  BMJ       Date:  2001-03-31

2.  Effect of screening programme on mortality from breast cancer. Benefit of 30% may be substantial overestimate.

Authors:  A B Miller
Journal:  BMJ       Date:  2000-12-16

Review 3.  Is clinical breast examination an acceptable alternative to mammographic screening?

Authors:  I Mittra; M Baum; H Thornton; J Houghton
Journal:  BMJ       Date:  2000-10-28

4.  Organized breast cancer screening programs in Canada.

Authors:  A B Miller
Journal:  CMAJ       Date:  2000-10-31       Impact factor: 8.262

5.  Breast self-examination.

Authors:  Tammy J Clifford; Margaret Sampson; Howard M Schachter
Journal:  CMAJ       Date:  2002-01-22       Impact factor: 8.262

6.  Recommendations on screening for breast cancer in average-risk women aged 40-74 years.

Authors:  Marcello Tonelli; Sarah Connor Gorber; Michel Joffres; James Dickinson; Harminder Singh; Gabriela Lewin; Richard Birtwhistle; Donna Fitzpatrick-Lewis; Nicole Hodgson; Donna Ciliska; Mary Gauld; Yan Yun Liu
Journal:  CMAJ       Date:  2011-11-22       Impact factor: 8.262

7.  Practical Applications for Clinical Breast Examination (CBE) and Breast Self-Examination (BSE) in Screening and Early Detection of Breast Cancer.

Authors:  Anthony B Miller
Journal:  Breast Care (Basel)       Date:  2008-02-08       Impact factor: 2.860

8.  [Bavarian mammography screening program].

Authors:  F Willgeroth; M Baumann; D Blaser; A Crispin; S Froschauer; J de Waal; S Heywang-Köbrunner; D Hölzel; V Kääb; R Rothe; V Stich; S Thomaschewski; D Walter
Journal:  Radiologe       Date:  2005-03       Impact factor: 0.635

9.  Screening for coronary heart disease: cardiology through the oncology looking glass.

Authors:  D Douglas Miller; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

Review 10.  Screening for breast cancer.

Authors:  Joann G Elmore; Katrina Armstrong; Constance D Lehman; Suzanne W Fletcher
Journal:  JAMA       Date:  2005-03-09       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.